• UMI3 gives exclusive licence for SenTraGor to Arriani Pharmaceuticals pharmaceutical-technology
    August 25, 2017
    The University of Manchester’s technology transfer company, UMI3, has entered an exclusive licence deal with Arriani Pharmaceuticals for a research tool that helps clarify the role of senescent cells in several age-related diseases, including cancer.
PharmaSources Customer Service